Supreme Court upholds Tennessee ban on transgender youth medical care

Supreme Court upholds Tennessee ban on transgender youth medical care


People hold rainbow-coloured umbrellas and flags at a demonstration as the U.S. Supreme Court hears arguments over an appeal by U.S. President Joe Biden’s administration of a lower court’s decision upholding a Republican-backed ban in Tennessee on gender-affirming medical care for transgender minors, outside the court in Washington, U.S., December 4, 2024. 

Benoit Tessier | Reuters

The Supreme Court on Wednesday upheld a Tennessee law restricting gender transition care for minors, delivering a major blow to transgender rights.

The 6-3 ruling is likely to have a broad impact as 24 other states have already enacted laws similar to the one in Tennessee, which bars gender transition surgery, puberty blockers and hormone therapy.

Those laws now look set to survive similar legal challenges. The ruling does not affect states that do not have such bans, meaning care in those states will still be available.

The court in an opinion authored by Chief Justice John Roberts concluded that the Tennessee law does not constitute a form of sex discrimination that would violate the Constitution’s 14th Amendment.

Trans rights activists have also warned that a ruling allowing bans on care for trans minors could pave the way for similar restrictions aimed at adults.

The legal challenge was brought by the administration of former President Joe Biden as well as transgender teens and their families.

The ruling does not definitely resolve all legal issues relating to the state bans as it did not address a separate argument under the 14th Amendment that the laws violate the right of parents to make health care decisions for their children.

Upon taking office in January, President Donald Trump has set about unwinding Biden policies that sought to bolster transgender rights. Among other things, he signed an executive order seeking to restrict gender-affirming care for teens nationwide A judge quickly blocked it.

Trump has also imposed new restrictions on transgender people serving in the military.

Upon taking office in January, President Donald Trump has set about unwinding Biden policies that sought to bolster transgender rights. Among other things, he signed an executive order seeking to restrict gender-affirming care for teens nationwide. A judge quickly blocked it.

Trump has also imposed new restrictions on transgender people serving in the military.

Enacted in 2023, the Tennessee law is among a wave of similar measures taken by states imposing restrictions on gender transition treatments. In defending its ban, the state’s lawyers pointed to similar measures taken in other countries, including in Europe.

Tennessee Attorney General Jonathan Skrmetti emphasized in court papers the evolving debate over how best to treat minors diagnosed with gender dysphoria, the clinical term given to the distress people can experience when their gender identities are in conflict with the genders assigned to them at birth.

Major medical organizations say gender-affirming treatments are an effective way to treat gender dysphoria.

The challengers argued that the law is a form of sex discrimination that violates the 14th Amendment’s equal protection clause because the treatments at issue in the case — puberty blockers and hormone therapy — can be used in other situations.

The case marks the most significant ruling on transgender rights since the court in 2020, to the surprise of many, ruled that federal employment protections extend to gender identity as well as sexual orientation.

The dispute reached the Supreme Court after the Cincinnati-based 6th U.S. Circuit Court of Appeals in 2023 rejected challenges to the Tennessee law and a similar measure in Kentucky.

A district court judge had blocked parts of the law, while concluding that plaintiffs did not have legal standing to challenge the surgery ban. That provision of the law was not at issue before the Supreme Court.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More